These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28987272)

  • 1. Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome.
    Caraci F; Iulita MF; Pentz R; Flores Aguilar L; Orciani C; Barone C; Romano C; Drago F; Cuello AC
    Eur J Pharmacol; 2017 Dec; 817():7-19. PubMed ID: 28987272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down syndrome and Alzheimer's disease: Common pathways, common goals.
    Hartley D; Blumenthal T; Carrillo M; DiPaolo G; Esralew L; Gardiner K; Granholm AC; Iqbal K; Krams M; Lemere C; Lott I; Mobley W; Ness S; Nixon R; Potter H; Reeves R; Sabbagh M; Silverman W; Tycko B; Whitten M; Wisniewski T
    Alzheimers Dement; 2015 Jun; 11(6):700-9. PubMed ID: 25510383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease associated with Down syndrome: a genetic form of dementia.
    Fortea J; Zaman SH; Hartley S; Rafii MS; Head E; Carmona-Iragui M
    Lancet Neurol; 2021 Nov; 20(11):930-942. PubMed ID: 34687637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Search for Biomarkers of Alzheimer's Disease in Down Syndrome.
    Handen BL
    Am J Intellect Dev Disabil; 2020 Mar; 125(2):97-99. PubMed ID: 32058812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21.
    Cannavo C; Tosh J; Fisher EMC; Wiseman FK
    Prog Brain Res; 2020; 251():181-208. PubMed ID: 32057307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome.
    Iulita MF; Cuello AC
    Trends Pharmacol Sci; 2014 Jul; 35(7):338-48. PubMed ID: 24962069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease.
    Ponnusamy R; McNerney MW; Moghadam S; Salehi A
    Brain Res; 2019 Jan; 1702():3-11. PubMed ID: 29102776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Down's syndrome and dementia].
    Parajuá-Pozo JL; Casis-Arguea S
    Rev Neurol; 2000 Jul 16-31; 31(2):126-8. PubMed ID: 10951667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials.
    Rafii MS
    CNS Drugs; 2020 Aug; 34(8):785-794. PubMed ID: 32506291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome.
    Granholm AC; Sanders L; Seo H; Lin L; Ford K; Isacson O
    Hippocampus; 2003; 13(8):905-14. PubMed ID: 14750653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal biomarkers in Down syndrome and Alzheimer's disease.
    Hamlett ED; Ledreux A; Potter H; Chial HJ; Patterson D; Espinosa JM; Bettcher BM; Granholm AC
    Free Radic Biol Med; 2018 Jan; 114():110-121. PubMed ID: 28882786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome.
    Patel A; Rees SD; Kelly MA; Bain SC; Barnett AH; Thalitaya D; Prasher VP
    Neurosci Lett; 2011 Jan; 487(2):144-8. PubMed ID: 20946940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome.
    Botté A; Potier MC
    Prog Brain Res; 2020; 251():209-243. PubMed ID: 32057308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease and Down's syndrome: treating two paths to dementia.
    Weksler ME; Szabo P; Relkin NR; Reidenberg MM; Weksler BB; Coppus AM
    Autoimmun Rev; 2013 Apr; 12(6):670-3. PubMed ID: 23201920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric symptoms in adults with Down syndrome and Alzheimer's disease.
    Urv TK; Zigman WB; Silverman W
    Am J Intellect Dev Disabil; 2010 Jul; 115(4):265-76. PubMed ID: 20597723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preamyloid deposits, amyloid deposits, and senile plaques in Alzheimer's disease, Down syndrome, and aging.
    Bugiani O; Tagliavini F; Giaccone G
    Ann N Y Acad Sci; 1991; 640():122-8. PubMed ID: 1837976
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving Memory and Cognition in Individuals with Down Syndrome.
    Rafii MS
    CNS Drugs; 2016 Jul; 30(7):567-73. PubMed ID: 27272473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Biomarker Outcomes into Clinical Trials for Alzheimer's Disease in Down Syndrome.
    Rafii MS; Zaman S; Handen BL
    J Prev Alzheimers Dis; 2021; 8(1):48-51. PubMed ID: 33336224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.